← Back to feedRead original →
VERIFIEDET Finance·positive
Zydus Lifesciences expects decent growth for five years as innovation matures: Sharvil Patel
AI Summary
- ·Zydus Lifesciences aims for double-digit revenue growth and improved profitability over the next five years.
- ·The company plans to focus on specialty medicines and biotechnology innovation, enhancing its oncology franchise.
- ·Discovery-led products are expected to contribute from 2030 onwards, strengthening its market position.